Home | Community | Message Board

Out-Grow.com - Mushroom Growing Kits & Supplies
This site includes paid links. Please support our sponsors.


Welcome to the Shroomery Message Board! You are experiencing a small sample of what the site has to offer. Please login or register to post messages and view our exclusive members-only content. You'll gain access to additional forums, file attachments, board customizations, encrypted private messages, and much more!

Shop: North Spore North Spore Mushroom Grow Kits & Cultivation Supplies   Unfolding Nature Unfolding Nature: Being in the Implicate Order   Mushroom-Hut Mono Tub Substrate   Left Coast Kratom Buy Kratom Extract   Kraken Kratom Kratom Capsules for Sale   Bridgetown Botanicals Bridgetown Botanicals   Original Sensible Seeds Autoflowering Cannabis Seeds   PhytoExtractum Buy Bali Kratom Powder

Jump to first unread post Pages: 1
Some of these posts are very old and might contain outdated information. You may wish to search for newer posts instead.
OfflineSunshineDaydreem
Midnight Toker

Registered: 08/29/06
Posts: 21
Last seen: 17 years, 3 months
Hallucinogens by David E. Nichols
    #6010825 - 08/30/06 05:30 AM (17 years, 4 months ago)
Log in to view attachment

(Edit - Attached the file since the link doesn't work)

Hey people,

Here is a very nice and informative scholarly journal article about hallucinogens in general that I thought you might enjoy.  It is quite long, so I have taken out several quotes that I found interesting/important (this is also quite long...).

The article can be found at http://www.sciencedirect.com/science?_ob...d62579&ref=full (I hope this link works).

Quote:

we shall review those substances that principally exert their central nervous system (CNS) effects by an agonist (or partial agonist) action at serotonin (5-HT)2A receptors

Many different names have been proposed over the years for this drug class. The famous German toxicologist Louis Lewin used the name phantastica earlier in this century [Lewin, 1964], and as we shall see later, such a descriptor is not so farfetched. The most popular names, hallucinogen, psychotomimetic, and psychedelic (“mind manifesting”; [Osmond, 1957]), have often been used interchangeably.

There is only a meager amount of factual information about hallucinogenic drugs among the general public today. Furthermore, in the scientific and medical communities, where one expects to find expertise on drugs, there is now a whole generation who knows almost nothing about hallucinogens other than the fact that they are subject to the strictest legal controls applied to any class of pharmacological agents

Despite their high degree of physiological safety and lack of dependence liability, hallucinogens have been branded by law enforcement officials as among the most dangerous drugs that exist, being placed into Schedule I of the Controlled Substances Act. Depending on the locale, especially in the United States, punishments for using or distributing drugs like LSD are often more draconian than if the user had committed a violent crime. Although there is a common perception that Schedule I drugs are particularly dangerous, the 3-pronged test for placement of a drug into schedule I requires only that (1) the drug has no currently accepted medical use in the United States, (2) there is a lack of safety for use of the drug under medical supervision, and (3) the substance has a high “potential for abuse.”

What is it, exactly, that makes these pharmacological curiosities so fearsome? The answer lies, in large measure, beyond hard science and within a complex sociological and political agenda that surround psychedelics, which is well outside the scope of this review. Nevertheless, a very brief discussion of the history and background of these unique substances is warranted to provide a little insight into how this situation arose.

Naturally occurring hallucinogenic drugs played a significant role in the development of philosophy and religious thought in many earlier cultures. One can argue persuasively that hallucinogenic drugs might have been catalysts for the development of humankind's earliest philosophies and theologies. How many Neolithic hunters, one might wonder, eking out an existence in the wild, were likely to sit before the fire at night contemplating the nature of man and the meaning of life? By contrast, if the same group had discovered and ingested some hallucinogenic mushrooms, they would be compelled to confront and would surely have discussed and attempted to understand the nature of their otherworldly mushroom-induced encounters. Assuming that their neurochemistry was not so different from ours today, those occurrences would have been well beyond the bounds of their everyday experiences and vocabulary. They could easily have concluded that these plants were “the residences of divinities or other spiritual forces” [Schultes & Hofmann, 1979].

The late Daniel X. Freedman, one of the great pioneers of LSD research, made comments consistent with that assessment, stating, “…one basic dimension of behavior…compellingly revealed in LSD states is “portentousness”—the capacity of the mind to see more than it can tell, to experience more than it can explicate, to believe in and be impressed with more than it can rationally justify, to experience boundlessness and “boundaryless” events, from the banal to the profound.” [Freedman, 1968]. It might be noted in this context that one doctoral dissertation has even provided evidence that psilocybin-induced mystical-religious experiences could not be distinguished, by objective criteria, from spontaneously occurring ones [Pahnke, 1963].

It should be apparent from the foregoing discussion that hallucinogens have a unique and powerful ability to affect the human psyche. They may alter one's concepts of reality, may change one's views on life and death, and can provoke and challenge one's most cherished beliefs. Therein, this writer believes, lay the roots of much of the fear and hysteria that these substances have fostered in our society.

Hallucinogens are generally considered to be physiologically safe molecules whose principal effects are on consciousness. That is, hallucinogens are powerful in producing altered states of consciousness (ASC), but they do so at doses that are not toxic to mammalian organ systems. There is no evidence that any of the hallucinogens, even the very powerful semisynthetic LSD, causes damage to any human body organ. [Cohen, 1967] has stated, “Death directly caused by the toxicity of LSD is unknown.” This statement was reiterated 20 years later by [Jaffe, 1985], “In man, deaths attributable to direct effects of LSD are unknown.” This observation still remains true today. Hallucinogens do not cause life-threatening changes in cardiovascular, renal, or hepatic function because they have little or no affinity for the biological receptors and targets that mediate vital vegetative functions.

In contrast to many other abused drugs, hallucinogens do not engender drug dependence or addiction and are not considered to be reinforcing substances [O'Brien, 2001]. It is generally believed that most if not all drugs that possess dependence liability have the ability to affect dopaminergic (DA) transmission, particularly in mesolimbic areas of the brain. The behavioral correlate of this effect is increased mood and often euphoria. By contrast, nearly all hallucinogens lack affinity either for DA receptors or for the DA uptake transporter and therefore do not directly affect DA neurotransmission. In an article reviewing drugs of abuse that activate brain reward pathways, drugs identified with this action included opiates, nicotine, cannabis, phencyclidine (PCP), cocaine, amphetamine, alcohol, benzodiazepines, barbiturates, and even caffeine, but there was no mention of hallucinogens [Wise, 1998].

There are no literature reports of successful attempts to train animals to self-administer classical hallucinogens, an animal model predictive of abuse liability, indicating that these substances do not possess the necessary pharmacology to either initiate or maintain dependence.

[Strassman, 1984] and [Halpern & Pope, 1999] have analyzed the published reports on adverse reactions and negative long-term sequelae following hallucinogen use. Halpern and Pope reached a conclusion similar to Strassman's earlier analysis that concerning repeated use of psychedelic drugs the results were controversial, but if any long-term adverse effect did occur it was “subtle or nonsignificant.” It should be noted, however, that in both studies their conclusions were specifically developed based on reviews of supervised clinical research with hallucinogens.

One adverse consequence of hallucinogen use is known as “flashbacks.” Flashbacks were widely discussed in the press, particularly in earlier decades, as one of the most common adverse effects of hallucinogens; their occurrence was emphasized as a deterrent to recreational use.

there appears to be no relationship between frequency of hallucinogen use and rate of occurrence.

There are, however, real and significant dangers that can accompany recreational use of these substances. Although LSD or other classical hallucinogens have not directly caused overdose death, fatal accidents during LSD intoxication have occurred [Jaffe, 1985]. This danger is significant, particularly when these drugs are used recreationally in unsupervised settings.

Less serious but still very substantial injuries can occur in unusual ways. For example, severe and irreversible ocular damage has resulted from prolonged staring at the sun by individuals under the influence of LSD [Schatz & Mendelblatt, 1973 and Fuller, 1976].

The most significant dangers of psychedelics, however, appear to lie principally in their psychological effects. LSD can induce disturbances of experience, otherwise observed only in psychoses, such as alteration of cognitive functions, and depersonalization. Hallucinogens can catalyze the onset of psychosis or depression, which has sometimes led to suicide, and [Cohen, 1960] has estimated the incidence of LSD-related psychosis to be about 8 per 10,000 subjects. In another study, one case of psychosis was reported in a survey of 247 LSD users [McGlothlin & Arnold, 1971]. Fortunately, however, these drugs do not appear to produce illness de novo in otherwise emotionally healthy persons, but these problems seem to be precipitated in predisposed individuals.

Bad trips can usually be treated successfully by “talk-down” therapy and administration of benzodiazepines.

A somewhat later study by [Vardy & Kay, 1983] compared patients hospitalized for LSD psychosis with first-break schizophrenics. In most respects, the LSD psychotics were fundamentally similar to schizophrenics in genealogy, phenomenology, and course of illness. Their findings support a model of LSD psychosis as a drug-induced schizophreniform reaction in persons vulnerable to both substance abuse and psychosis.

Although these studies demonstrate a significant danger of LSD use, the number of such reports is very small relative to the numbers of persons who are believed to have self-administered LSD in recreational settings. A search of Medline in early 2003 for case reports of LSD-induced psychosis found only three reports in the previous 20 years.

The chemical structures of hallucinogens can be classified into two broad categories: (1) the tryptamines and (2) the phenethylamines. Within the tryptamines, however, one should probably include two subsets, the simple tryptamines such as DMT, 5-methoxy-DMT (5-MeO-DMT), and psilocybin, which possess considerable conformational flexibility, and the ergolines, relatively rigid analogues including LSD and a few very closely related compounds.

Our modern awareness of hallucinogens began on Friday, April 16, 1943, when Albert Hofmann, a natural products chemist with Sandoz Pharmaceuticals in Basel, Switzerland, experienced unusual mental effects following work with LSD-25, the diethylamide of lysergic acid [Hofmann, 1979 and Hofmann, 1994]. His suspicion that the effects he had experienced on the previous Friday were due to accidental exposure to a tiny unknown amount of LSD were confirmed three days later on April 19 by his deliberate oral ingestion of a solution containing 0.25 mg of LSD tartrate, a relatively large dose of this substance. On that occasion, the effects were very profound and left no doubt that the unusual intoxication of the previous Friday had been due to ingestion of LSD. No drug had been discovered up to that time that possessed such high potency, so the research management at Sandoz was initially skeptical of Dr. Hofmann's report.

Dosage forms available on the illicit market today are typically 0.04–0.06 mg, whereas in past years they were more often in the 0.10–0.20 mg range; in the late 1960s, tablets were often found that contained 0.25 mg or more.

In contrast to virtually every other class of CNS drug, where the action is usually predictable, the effects of hallucinogens are heavily dependent on the expectations of the user (“set”) and the environment (“setting”) in which the use takes place. Indeed, no clinician experienced with these substances would fail to consider set and setting as primary determinants of the experience. Thus, expectations and environments that would foster religious or spiritual experiences increase the probability of the drug producing such an effect. Conversely, use in a nonstructured, unwise, or recreational way can have unpredictable and even disastrous psychological consequences. Early clinical research, where LSD was expected to produce a model psychosis (recall the term “psychotomimetic”), was not designed to discover positive effects of these substances. Subjects given LSD in a clinical ward and counseled that they might experience schizophrenia-like symptoms indeed often did suffer panic, anxiety, negative effects, and feelings of insanity.

Dr. Stanislov Grof, who supervised more clinical LSD sessions than any other individual, wrote, “I consider LSD to be a powerful unspecific amplifier or catalyst of biochemical and physiological processes in the brain” [Grof, 1975]. These thoughts were echoed by [Barr et al., 1972] who stated, “…the phenomena induced by LSD (and probably by any similar drug) cannot be predicted or understood in purely pharmacological terms; the personality of the drug taker plays an enormous and critical role in determining how much effect there will be and of what particular type.”

This psychological state has often been referred to in the popular press as a “peak experience,” “transcendent,” or “mystical” experience and is a profoundly ASC. The user may feel transported to an alternate time or place, another dimension, or another plane of existence that may seem completely real. It is this experience that has been described as having parallels to the near death experience (NDE; [Grof & Grof, 1980]) and appears to have the most profound and long-lasting effects on the user. This state is of particular relevance to the definition of psychedelic and is emphasized in the term entheogen as noted earlier. Although this effect more often is achieved with high doses of hallucinogens, it can occur unpredictably and independently of the dose.

Surveys have shown that hallucinogen use is most likely to occur in the late teens and into the early 20s but does not usually continue after users reach their late 20s [Chilcoat & Schutz, 1996]. Chronic use of hallucinogens is unusual [Henderson, 1994 and Chilcoat & Schutz, 1996]. This use pattern is in distinct contrast to the compulsive abuse that is often seen with rewarding drugs such as amphetamines, cocaine, or the opiates, which produce craving.

When asked why they use hallucinogens, individuals who take doses with significant psychological effects often say that they use them for personal or spiritual development and increased understanding and self-discovery, that their use seems important to them, and that often they feel they gain important personal, religious, or philosophical insights. These sorts of perceptions might arise as a consequence of markedly affecting cognitive processing in the frontal cortex, the area of the brain where executive decisions and the assessment of significance occurs [Goldberg, 2001]. This reasoning may explain why humans take psychedelics, although they do not have rewarding effects in animal models: the nature of the reinforcement in humans is primarily cognitive, from perceptions of greater awareness, increased understanding, or profound insights that would have no counterpart in lower species with a less developed frontal cortex.

Following the isolation and identification of 5-HT, interest in its role as a neurotransmitter and its possible relevance to behavior was greatly stimulated by the virtually contemporaneous discovery of LSD and recognition that this potent psychoactive substance had the ability to interact with 5-HT systems.

Although at first it may be difficult to understand how the reversible acute receptor effects of hallucinogens could precipitate mental illness, there may be a small population of individuals particularly sensitive to gene expression changes in which the alterations could tip the balance toward the development of long-lasting psychiatric disorders. Persistent alterations in gene expression might also be important as an underlying component of HPPD (discussed earlier).

The clinical studies of DMT were also prompted by the fact that this substance is found naturally in mammalian brain and it might therefore be an endogenous psychotogen or psychosis-producing substance.

Of all the proposed medical indications for hallucinogens, one of the more interesting and well-documented uses, particularly for LSD, was in the treatment of terminal patients. [Kast & Collins, 1964] originally reported that LSD had an analgesic effect in dying patients that far outlasted its acute psychological effects. Their initial observation was that patients for whom this effect occurred seemed to have changed their attitudes toward death. Later studies led [Kast, 1966 and Kast, 1970] to the conclusion that LSD treatment resulted in improved psychological adjustment in dying patients, made them more responsive to their families and environments, and enhanced their ability to enjoy everyday life.

The original motivation for using a hallucinogen in the treatment of alcoholism was based on speculation that the effects of LSD might be similar to delirium tremens, the negative consequences of which might help to deter alcohol use. Unfortunately, the question of whether LSD treatment is effective for alcoholism was never convincingly answered.

Additional recent anecdotal studies have provided further evidence that use of hallucinogens may alleviate symptoms of OCD [Moreno & Delgado, 1997 and Delgado & Moreno, 1998].

In a third set of experiments, these investigators studied the ability of DMT to produce tolerance, a phenomenon that occurs with the hallucinogens LSD, mescaline, and psilocybin and discussed earlier in this review. Obviously, tolerance could not be produced by an endogenous hallucinogen because psychosis is a chronic and ongoing process. Four sequential doses of 0.3 mg/kg i.v. DMT fumarate were administered, separated at half-hour intervals. There was no evidence of tolerance to the effects of DMT and the authors note that this finding would be consistent with hypotheses that DMT could occur as an endogenous psychotogen [Strassman et al., 1996].

Although psilocybin had no effect on direct semantic priming, it did increase indirect semantic priming. Their data suggest that psilocybin leads to increased availability of remote associations, thereby bringing cognitive contents to mind that would normally remain inactivated.

The field of cognitive neuroscience has addressed the challenge of attempting to understand consciousness and how it arises in the brain. Surely, the most potent drugs known that alter consciousness, the hallucinogens, should play a role in that investigation.

It is now understood that there is no “seat” of consciousness and that consciousness is not a property of a single brain location but more likely arises as the result of dynamic interactions among widely distributed groups of neurons that integrate a very large number of sensory inputs and motor responses occurring in parallel. [Edelman, 1989] has emphasized that consciousness concerns the rapid integration of signals from a great variety of modalities and submodalities to create a unified, coherent scene or idea. He suggests that the number of possible conscious states is enormous.

The philosopher in each of us yearns for greater understanding of who we are and why we are here. Irrational fear of inquiries into the nature of consciousness and conscious experience must be put aside, and hallucinogens should be recognized for what they are: tools that will ultimately help us to understand ourselves. The answers lie in further research for somewhere in the complexity of the brain exists the source of answers to all questions about ourselves. In the coming years, we may look forward to substantial progress in understanding how hallucinogens affect brain function, how those changes alter perception and cognition, and ultimately whether these ancient healing substances have medical value and wisdom to impart to our modern age.




Enjoy and take it easy  :rasta:


Edited by SunshineDaydreem (08/30/06 03:32 PM)


Extras: Filter Print Post Top
Invisiblebadchad
Mad Scientist

Registered: 03/02/05
Posts: 13,372
Re: Hallucinogens by David E. Nichols [Re: SunshineDaydreem]
    #6010910 - 08/30/06 06:40 AM (17 years, 4 months ago)

Better late than never I guess.

Some people may have trouble with the link as institutional access is usually required for these articles.


--------------------
...the whole experience is (and is as) a profound piece of knowledge.  It is an indellible experience; it is forever known.  I have known myself in a way I doubt I would have ever occurred except as it did.

Smith, P.  Bull. Menninger Clinic (1959) 23:20-27; p. 27.

...most subjects find the experience valuable, some find it frightening, and many say that is it uniquely lovely.

Osmond, H.  Annals, NY Acad Science (1957) 66:418-434; p.436


Extras: Filter Print Post Top
Invisibleredgreenvines
irregular verb
 User Gallery

Registered: 04/08/04
Posts: 37,526
Re: Hallucinogens by David E. Nichols [Re: badchad]
    #6010977 - 08/30/06 08:05 AM (17 years, 4 months ago)

I was glad however to read the excerpt.
thanks


--------------------
:confused: _ :brainfart:🧠  _ :finger:


Extras: Filter Print Post Top
OfflineSunshineDaydreem
Midnight Toker

Registered: 08/29/06
Posts: 21
Last seen: 17 years, 3 months
Re: Hallucinogens by David E. Nichols [Re: redgreenvines]
    #6012114 - 08/30/06 03:33 PM (17 years, 4 months ago)

Figures it wouldn't work, Attached the file - enjoy


--------------------
Sunshine daydream
Walk you the tall trees
Going where the wind goes
Blooming like a red rose
Breathing more freely
Light out singing
I'll walk you in the morning sunshine
Sunshine daydream
Walk you in the sunshine


Extras: Filter Print Post Top
Invisibleelbisivni
Registered: 10/01/06
Posts: 2,839
Re: Hallucinogens by David E. Nichols [Re: SunshineDaydreem]
    #6573094 - 02/15/07 11:47 PM (16 years, 11 months ago)

:bump:

Excellent article, great source.  I'll probably hang on to this as reference for a while.  It's really sad that even with such great intensive research and writing an overwhelming majority of politicians and doctors still will not even consider such information.


--------------------
From dust you are made and to dust you shall return.


Extras: Filter Print Post Top
Offlinevigilant_mind
unfazed
Male User Gallery

Registered: 01/19/07
Posts: 1,717
Loc: boco
Last seen: 14 years, 6 months
Re: Hallucinogens by David E. Nichols [Re: elbisivni]
    #6573119 - 02/15/07 11:52 PM (16 years, 11 months ago)

Quote:

Although there is a common perception that Schedule I drugs are particularly dangerous, the 3-pronged test for placement of a drug into schedule I requires only that (1) the drug has no currently accepted medical use in the United States, (2) there is a lack of safety for use of the drug under medical supervision, and (3) the substance has a high “potential for abuse.”




I guess the DEA feels that alcohol is exempt from this criteria.


Extras: Filter Print Post Top
OfflineFlugon_Nine
Rolling Stone
Male

Registered: 01/29/07
Posts: 110
Loc: Earth A.D.
Last seen: 15 years, 2 months
Re: Hallucinogens by David E. Nichols [Re: vigilant_mind]
    #6573154 - 02/16/07 12:01 AM (16 years, 11 months ago)

I always thought the government using addiction to help rake in money was a valid medical use.:grin:


--------------------
"When we first broke into that forbidden box in the other dimension, we knew we had discovered something as surprising and powerful as the New World when Columbus came stumbling onto it." - Ken Kesey



Extras: Filter Print Post Top
Invisibleelbisivni
Registered: 10/01/06
Posts: 2,839
Re: Hallucinogens by David E. Nichols [Re: vigilant_mind]
    #6573167 - 02/16/07 12:03 AM (16 years, 11 months ago)

Tobacco as well, as different as they may be. It really is astounding.

Estimated Per Capita Death Rates by Drugs
UK Drug Deaths
Annual Causes of Death in the United States
Drug Facts And Statistics
How Many People Die From Using Drugs?
Statistics prove prescription drugs are 16,400% more deadly than terrorists

The list goes on and on and on, it blows my mind. What is there seriously left to argue?


--------------------
From dust you are made and to dust you shall return.


Extras: Filter Print Post Top
Offlineozzyozzyozzy
Australian
 User Gallery

Registered: 10/23/06
Posts: 545
Last seen: 3 years, 8 months
Re: Hallucinogens by David E. Nichols [Re: elbisivni]
    #6573301 - 02/16/07 12:56 AM (16 years, 11 months ago)

The fact that LSD makes you go insane and ecstasy kills you, of course. Naturally. Oh, you're arguing against it? Stop defending your habits, you crazed addict. Get out of my country! Police, police!


Extras: Filter Print Post Top
OfflineXtals
Stranger
Registered: 01/06/07
Posts: 207
Last seen: 16 years, 10 months
Re: Hallucinogens by David E. Nichols [Re: elbisivni]
    #6573307 - 02/16/07 12:59 AM (16 years, 11 months ago)

Isn't this article already on this site somewhere?

I'm just curious, but what exactly would doctors have to consider about this information? What is it that you think they're not considering? Doctors aren't involved in the political process of scheduling these drugs and since most general practicioners wouldn't be prescribing LSD or the like, what do they need to consider?

Also, there are doctors who do reseach in this field.

I'm just confused as to why you seem to be pointing the finger at doctors for something.

The article is about 50 pages long and quite good.


Extras: Filter Print Post Top
Invisibleelbisivni
Registered: 10/01/06
Posts: 2,839
Re: Hallucinogens by David E. Nichols [Re: Xtals]
    #6573482 - 02/16/07 01:59 AM (16 years, 11 months ago)

Maybe it is.

Doctors have their job security to consider. They make their money prescribing medication. They denounce what are politically considered illicit chemicals.

More importantly, I was off-handedly referring to pharmaceutical companies. The medications they push are required daily, usually for very extended periods of time, that's where the money is. Though the drugs we're talking about here may not replace all prescription medications they would definitely knock a considerable amount out of the market. When such companies bring these substances into their line-up they find that they are not reliable sources of the excessive income they've grown to love. Maybe you need it once, maybe twice, maybe one-hundred times - throughout your lifetime. Furthermore, people could synthesize/grow/harvest these substances on their own terms, as they have been, for a fraction of the cost (even if they remain illegal to produce).

Yes, there are doctors who do research in this field, but not many, and not with proper funding or even the ability to study the chemical itself, first hand, due to it's illegality.

Legal Drug Pusher
The Truth About the Drug Companies
Drug Legalization: Who Is Fooling Whom?
Why Is There A War On Drugs?
Thinking About Drug Legalization


--------------------
From dust you are made and to dust you shall return.


Extras: Filter Print Post Top
OfflineXtals
Stranger
Registered: 01/06/07
Posts: 207
Last seen: 16 years, 10 months
Re: Hallucinogens by David E. Nichols [Re: elbisivni]
    #6573547 - 02/16/07 02:39 AM (16 years, 11 months ago)

Though the drugs we're talking about here may not replace all prescription medications they would definitely knock a considerable amount out of the market.

That is just nonsense. You really think that psychedelics would even put a dent in the number of drugs on the market? You're out of your mind if you that. There is such a huge variety of different drugs out there that psychedelics would represent just another puny, tiny fraction of the drug market. I don't think that any pharmaceutical company would be remotely threatened if something like psilocin were suddenly for sale. Their market share would barely be affected. Sorry, but what you're saying is total and utter nonsense. Psychedelics simply have not been proven to be the great medications that you're implying they are. For the most part, things like LSD, psilocybin, DMT, MDMA = medically useless street dope.


Blaming pharmaceutical companies is just absurd.

When such companies bring these substances into their line-up they find that they are not reliable sources of the excessive income they've grown to love.

Nonsense, again. The pharmaceutical industry certainly deserves some bad press, but it gets far more bad press than it deserves. Drugs cost a lot of fucking money to make. We're talking $750 million to $1.5 billion in R&D. A patent lasts 20 years and it will take about 5 to 10 years to get the drug on the market, so that company only has 10 to 15 years to make back all that money, before even starting to make a profit.

Too many people point the finger at drug companies, unjustifiably. They're neccessary. Unless you want to pay huge taxes, public funding wouldn't do jack shit for us (we wouldn't be finding new medications).

Yes, there are doctors who do research in this field, but not many, and not with proper funding or even the ability to study the chemical itself, first hand, due to it's illegality.

Wrong again. You can get licences to be exempt from controlled substancces legislation. Just for example, a colleague of mine recently was exempted from the ban on cocaine possession for a short period of time (unfortunately the cocaine went "missing" in the mail - but that's a different story). If you search PubMed for "lysergic acid diethylamide" you'll get over 4000 hits, with many articles being published recently and they often require actual possession of the substance in question. You can easily search for yourself, but what you're saying is just plain old wrong. There's been a resurgent interest in psychedelics over the last few years. For example:

A role for psychedelics in psychiatry?. Br J Psychiatry. 2005 Nov;187:483;

The medications they push are required daily, usually for very extended periods of time, that's where the money is

That also just happens to be how it has to be. Until gene therapy plays a bigger role, drugs will have to be taken constantly. You do understand that the fact that we metabolize and excrete drugs means that we have to take them on a regular basis, right? This is also required for low toxicity, because drugs with long half-lives can build up and cause toxicity problems.

Honestly, people are too ready to blame pharmaceutical companies. There probably are a lot of jerks working for them, but there are a lot of genuinely well meaning people working at pharmaceutical companies too. Drugs are VERY expensive to make and there simply isn't any getting around the cost. Now, I agree that a lot of the marketing for drugs is just terrible (I don't like seeing Viagra or Cialis ads on TV and think that should be banned) and some 'medical problems' seem entirely made up ("male menopause").


Extras: Filter Print Post Top
Invisibleelbisivni
Registered: 10/01/06
Posts: 2,839
Re: Hallucinogens by David E. Nichols [Re: Xtals]
    #6573613 - 02/16/07 03:30 AM (16 years, 11 months ago)

Good information, too bad it has been smothered in foolish assumptions and a condescending self-righteous attitude. Anyway, thanks for the info.

I rephrase the post that upset you so to: Too bad it won't make a big difference.


--------------------
From dust you are made and to dust you shall return.


Extras: Filter Print Post Top
OfflineschmutzenS
King of the side-pins
 User Gallery

Registered: 12/03/02
Posts: 15,304
Loc: Miss Kitty's Lounge
Last seen: 4 hours, 15 minutes
Re: Hallucinogens by David E. Nichols [Re: Xtals]
    #6573844 - 02/16/07 07:56 AM (16 years, 11 months ago)

They rely on the patient coming back, if he/she got well they'd be out of a job.

"We're talking $750 million to $1.5 billion in R&D"

They're lying.

Andropause is real.


--------------------


"Blow up your TV, throw away your paper.  Go to the country, build you a home."


Extras: Filter Print Post Top
Jump to top Pages: 1

Shop: North Spore North Spore Mushroom Grow Kits & Cultivation Supplies   Unfolding Nature Unfolding Nature: Being in the Implicate Order   Mushroom-Hut Mono Tub Substrate   Left Coast Kratom Buy Kratom Extract   Kraken Kratom Kratom Capsules for Sale   Bridgetown Botanicals Bridgetown Botanicals   Original Sensible Seeds Autoflowering Cannabis Seeds   PhytoExtractum Buy Bali Kratom Powder


Similar ThreadsPosterViewsRepliesLast post
* Accidental & Deliberate Shroom Ingestions in Australia & NZ mjshroomer 5,536 1 06/04/03 03:27 AM
by Zen Peddler
* How Hallucinogenic Drugs Work
( 1 2 3 4 5 6 all )
mjshroomer 75,393 117 08/13/14 05:49 AM
by omegafaust
* my schizofrenic friend (who got it from doing hallucinogens) is going to smoke salvia
( 1 2 3 all )
dubbyah 5,998 41 02/09/06 03:26 AM
by DinahTheCat
* Grade A++ Amanitas!!
( 1 2 all )
Psy Baba 5,000 23 04/15/06 09:52 AM
by thedudenj
* taking very high doses of THC/weed
( 1 2 3 all )
keefboy 20,326 51 04/14/15 02:08 AM
by Indole8
* Questions on hallucinogen use in ancient mesoamerica. *essay posted* runnerup 6,136 19 12/11/04 01:25 AM
by runnerup
* Phenylethylamine in Hallucinogenic Psilocybe Mushrooms kottonmouthss 3,549 10 07/24/04 09:27 AM
by Hanky
* poisonous hallucinogens? dalorean 2,002 19 07/02/02 02:07 PM
by PsilocybicMind

Extra information
You cannot start new topics / You cannot reply to topics
HTML is disabled / BBCode is enabled
Moderator: psilocybinjunkie, Rose, mushboy, LogicaL Chaos, Northerner, bodhisatta
4,262 topic views. 2 members, 59 guests and 13 web crawlers are browsing this forum.
[ Show Images Only | Sort by Score | Print Topic ]
Search this thread:

Copyright 1997-2024 Mind Media. Some rights reserved.

Generated in 0.029 seconds spending 0.012 seconds on 14 queries.